Nitric oxide synthase inhibition with N(G)-mono-methyl-L-arginine reversibly decreases cerebral blood flow in piglets

R. S. Greenberg, M. A. Helfaer, Jeffrey Kirsch, L. E. Moore, R. J. Traystman

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Objective: We tested the hypothesis that, in piglets, the intravenous administration of the reversible inhibitor of nitric oxide synthase, N(G)- mono-methyl-L-arginine, decreases cerebral blood flow via a mechanism unrelated to cerebral oxygen consumption. Design: Prospective, randomized, controlled animal study. Setting: Animal laboratory at a university. Subjects: Pentobarbital-anesthetized piglets (1 to 2 wks of age; 2.6 to 4.0 kg). Interventions: Piglets were treated with either 50 mg of N(G)-mono- methyl-L-arginine, 100 mg of N(G)-mono-methyl-L-arginine, or an equal volume of saline by intravenous infusion over 10 mins. Measurements and Main Results: Mean arterial pressure increased after N(G)-mono-methyl-L-arginine (50 mg dose: 84 ± 6 to 100 ± 7 mm Hg; 100 mg dose: 82 ± 4 to 107 ± 4 mm Hg; p <.001). Forebrain blood flow (microspheres) decreased (37 ± 2 to 30 ± 2 mL/min/100 g; p <.05) and cerebrovascular resistance increased (2.1 ± 0.2 to 3.5 ± 0.3 mm Hg/mL/min/100 g; p <.05) only after 100 mg of N(G)- mono-methyl-L-arginine. Neurohypophysis blood flow decreased to 56 ± 9% of the control value, while forebrain blood flow decreased only to 81 ± 4% of the control value after 100 mg of N(G)-mono-methyl-L-arginine administration. Blood flow returned to control values by 30 mins after infusion. N(G)-mono- methyl-L-arginine administration had no effect on cerebral oxygen consumption at either dose. Intravenous administration of L-arginine (300 mg) immediately after the infusion of 100 mg of N(G)-mono-methyl-L-arginine was associated with prompt (by 3 mins) recovery of blood flow to all brain regions that were affected by N(G)-mono-methyl-L-arginine. Conclusions: These data suggest that nitric oxide and/or a nitric oxide-containing substance is an important mediator of cerebrovascular tone in piglets, acting via a mechanism unrelated to altering cerebral oxygen consumption.

Original languageEnglish (US)
Pages (from-to)384-392
Number of pages9
JournalCritical Care Medicine
Volume22
Issue number3
StatePublished - 1994
Externally publishedYes

Fingerprint

Cerebrovascular Circulation
Nitric Oxide Synthase
Arginine
Oxygen Consumption
Prosencephalon
Intravenous Administration
Nitric Oxide
Posterior Pituitary Gland
Laboratory Animals
Pentobarbital
Microspheres
Intravenous Infusions

Keywords

  • blood gas analysis
  • cerebral blood flow
  • critical illness
  • endothelium-derived relaxant factor
  • microspheres
  • neurologic emergencies
  • nitric oxide
  • oxygen consumption
  • vascular biology
  • vascular resistance

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Nitric oxide synthase inhibition with N(G)-mono-methyl-L-arginine reversibly decreases cerebral blood flow in piglets. / Greenberg, R. S.; Helfaer, M. A.; Kirsch, Jeffrey; Moore, L. E.; Traystman, R. J.

In: Critical Care Medicine, Vol. 22, No. 3, 1994, p. 384-392.

Research output: Contribution to journalArticle

Greenberg, R. S. ; Helfaer, M. A. ; Kirsch, Jeffrey ; Moore, L. E. ; Traystman, R. J. / Nitric oxide synthase inhibition with N(G)-mono-methyl-L-arginine reversibly decreases cerebral blood flow in piglets. In: Critical Care Medicine. 1994 ; Vol. 22, No. 3. pp. 384-392.
@article{b0fafc6d99884479a9f2b30c32b66fb5,
title = "Nitric oxide synthase inhibition with N(G)-mono-methyl-L-arginine reversibly decreases cerebral blood flow in piglets",
abstract = "Objective: We tested the hypothesis that, in piglets, the intravenous administration of the reversible inhibitor of nitric oxide synthase, N(G)- mono-methyl-L-arginine, decreases cerebral blood flow via a mechanism unrelated to cerebral oxygen consumption. Design: Prospective, randomized, controlled animal study. Setting: Animal laboratory at a university. Subjects: Pentobarbital-anesthetized piglets (1 to 2 wks of age; 2.6 to 4.0 kg). Interventions: Piglets were treated with either 50 mg of N(G)-mono- methyl-L-arginine, 100 mg of N(G)-mono-methyl-L-arginine, or an equal volume of saline by intravenous infusion over 10 mins. Measurements and Main Results: Mean arterial pressure increased after N(G)-mono-methyl-L-arginine (50 mg dose: 84 ± 6 to 100 ± 7 mm Hg; 100 mg dose: 82 ± 4 to 107 ± 4 mm Hg; p <.001). Forebrain blood flow (microspheres) decreased (37 ± 2 to 30 ± 2 mL/min/100 g; p <.05) and cerebrovascular resistance increased (2.1 ± 0.2 to 3.5 ± 0.3 mm Hg/mL/min/100 g; p <.05) only after 100 mg of N(G)- mono-methyl-L-arginine. Neurohypophysis blood flow decreased to 56 ± 9{\%} of the control value, while forebrain blood flow decreased only to 81 ± 4{\%} of the control value after 100 mg of N(G)-mono-methyl-L-arginine administration. Blood flow returned to control values by 30 mins after infusion. N(G)-mono- methyl-L-arginine administration had no effect on cerebral oxygen consumption at either dose. Intravenous administration of L-arginine (300 mg) immediately after the infusion of 100 mg of N(G)-mono-methyl-L-arginine was associated with prompt (by 3 mins) recovery of blood flow to all brain regions that were affected by N(G)-mono-methyl-L-arginine. Conclusions: These data suggest that nitric oxide and/or a nitric oxide-containing substance is an important mediator of cerebrovascular tone in piglets, acting via a mechanism unrelated to altering cerebral oxygen consumption.",
keywords = "blood gas analysis, cerebral blood flow, critical illness, endothelium-derived relaxant factor, microspheres, neurologic emergencies, nitric oxide, oxygen consumption, vascular biology, vascular resistance",
author = "Greenberg, {R. S.} and Helfaer, {M. A.} and Jeffrey Kirsch and Moore, {L. E.} and Traystman, {R. J.}",
year = "1994",
language = "English (US)",
volume = "22",
pages = "384--392",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Nitric oxide synthase inhibition with N(G)-mono-methyl-L-arginine reversibly decreases cerebral blood flow in piglets

AU - Greenberg, R. S.

AU - Helfaer, M. A.

AU - Kirsch, Jeffrey

AU - Moore, L. E.

AU - Traystman, R. J.

PY - 1994

Y1 - 1994

N2 - Objective: We tested the hypothesis that, in piglets, the intravenous administration of the reversible inhibitor of nitric oxide synthase, N(G)- mono-methyl-L-arginine, decreases cerebral blood flow via a mechanism unrelated to cerebral oxygen consumption. Design: Prospective, randomized, controlled animal study. Setting: Animal laboratory at a university. Subjects: Pentobarbital-anesthetized piglets (1 to 2 wks of age; 2.6 to 4.0 kg). Interventions: Piglets were treated with either 50 mg of N(G)-mono- methyl-L-arginine, 100 mg of N(G)-mono-methyl-L-arginine, or an equal volume of saline by intravenous infusion over 10 mins. Measurements and Main Results: Mean arterial pressure increased after N(G)-mono-methyl-L-arginine (50 mg dose: 84 ± 6 to 100 ± 7 mm Hg; 100 mg dose: 82 ± 4 to 107 ± 4 mm Hg; p <.001). Forebrain blood flow (microspheres) decreased (37 ± 2 to 30 ± 2 mL/min/100 g; p <.05) and cerebrovascular resistance increased (2.1 ± 0.2 to 3.5 ± 0.3 mm Hg/mL/min/100 g; p <.05) only after 100 mg of N(G)- mono-methyl-L-arginine. Neurohypophysis blood flow decreased to 56 ± 9% of the control value, while forebrain blood flow decreased only to 81 ± 4% of the control value after 100 mg of N(G)-mono-methyl-L-arginine administration. Blood flow returned to control values by 30 mins after infusion. N(G)-mono- methyl-L-arginine administration had no effect on cerebral oxygen consumption at either dose. Intravenous administration of L-arginine (300 mg) immediately after the infusion of 100 mg of N(G)-mono-methyl-L-arginine was associated with prompt (by 3 mins) recovery of blood flow to all brain regions that were affected by N(G)-mono-methyl-L-arginine. Conclusions: These data suggest that nitric oxide and/or a nitric oxide-containing substance is an important mediator of cerebrovascular tone in piglets, acting via a mechanism unrelated to altering cerebral oxygen consumption.

AB - Objective: We tested the hypothesis that, in piglets, the intravenous administration of the reversible inhibitor of nitric oxide synthase, N(G)- mono-methyl-L-arginine, decreases cerebral blood flow via a mechanism unrelated to cerebral oxygen consumption. Design: Prospective, randomized, controlled animal study. Setting: Animal laboratory at a university. Subjects: Pentobarbital-anesthetized piglets (1 to 2 wks of age; 2.6 to 4.0 kg). Interventions: Piglets were treated with either 50 mg of N(G)-mono- methyl-L-arginine, 100 mg of N(G)-mono-methyl-L-arginine, or an equal volume of saline by intravenous infusion over 10 mins. Measurements and Main Results: Mean arterial pressure increased after N(G)-mono-methyl-L-arginine (50 mg dose: 84 ± 6 to 100 ± 7 mm Hg; 100 mg dose: 82 ± 4 to 107 ± 4 mm Hg; p <.001). Forebrain blood flow (microspheres) decreased (37 ± 2 to 30 ± 2 mL/min/100 g; p <.05) and cerebrovascular resistance increased (2.1 ± 0.2 to 3.5 ± 0.3 mm Hg/mL/min/100 g; p <.05) only after 100 mg of N(G)- mono-methyl-L-arginine. Neurohypophysis blood flow decreased to 56 ± 9% of the control value, while forebrain blood flow decreased only to 81 ± 4% of the control value after 100 mg of N(G)-mono-methyl-L-arginine administration. Blood flow returned to control values by 30 mins after infusion. N(G)-mono- methyl-L-arginine administration had no effect on cerebral oxygen consumption at either dose. Intravenous administration of L-arginine (300 mg) immediately after the infusion of 100 mg of N(G)-mono-methyl-L-arginine was associated with prompt (by 3 mins) recovery of blood flow to all brain regions that were affected by N(G)-mono-methyl-L-arginine. Conclusions: These data suggest that nitric oxide and/or a nitric oxide-containing substance is an important mediator of cerebrovascular tone in piglets, acting via a mechanism unrelated to altering cerebral oxygen consumption.

KW - blood gas analysis

KW - cerebral blood flow

KW - critical illness

KW - endothelium-derived relaxant factor

KW - microspheres

KW - neurologic emergencies

KW - nitric oxide

KW - oxygen consumption

KW - vascular biology

KW - vascular resistance

UR - http://www.scopus.com/inward/record.url?scp=0028207366&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028207366&partnerID=8YFLogxK

M3 - Article

VL - 22

SP - 384

EP - 392

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 3

ER -